Yahoo Finance

Azurity Pharmaceuticals announces the FDA Approval of XIFYRM™ (meloxicam injection) for the Management of Moderate-to-Severe Pain in Adults

WOBURN, Mass., June 10, 2025 /PRNewswire/ -- Azurity Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved XIFYRM™ (meloxicam injection), an IV ...
Yahoo Finance

Baudax Bio Announces Publication of ANJESO® Network Meta-Analysis in the Peer-Reviewed Journal BMC Anesthesiology

MALVERN, Pa., Nov. 20, 2020 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced the online publication of a ...
Business Insider

Baudax Bio’s ANJESO® Achieves Formulary Listing at Over 100 Institutions in Less Than One Year on the Market

MALVERN, Pa., June 08, 2021 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on developing and commercializing innovative products for acute care settings, today ...
FierceBiotech

Encore Therapeutics Inc. Announces Successful Proof of Concept Study on Meloxicam Depot Injection

CARLSBAD, Calif., Oct 18, 2011 (BUSINESS WIRE) -- Encore Therapeutics Inc. (ETI) today announced that it successfully completed a pre-clinical Proof of Concept (POC) study on ETI-511, its proprietary, ...
Business Wire

United States ANJESO (meloxicam) Drug Insight and Market Forecasts, 2019-2022 and 2023-2032 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "United States ANJESO Drug Insight and Market Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's offering. This report provides comprehensive ...